PharmaCyte Biotech Inc (PMCB)

[Daphnis]

Subscription credit facilities provided by a lender (GEM) typically involve a pledge by the fund borrower (Ausrianova) and its general partner or other managing entity (PMCB) to:
•The right in and to the unfunded capital commitments of the -investors-
•The right to make capital calls and to enforce the obligations of the -investors- to contribute capital; and
•The deposit account into which -investors- are required to fund their contributions.

Lender (GEM Global Yield LLC SCS)
Fund (Austrianova IPO)
Partner or Managing Entity of Fund (PMCB)
Investors (GEM, 3rd Party, SPAC, future Aus-IPO investors)

https://www.einnews.com/pr_news/539088704/austrianova-secures-100-million-usd-investment-commitment-from-gem-as-company-seeks-to-go-public